PLD Chemotherapy Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Pegylated liposomal doxorubicin

Filter by location:

Chicago, Illinois1 trial

CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer

University of Chicago Comprehensive Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.